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Cat scratch disease (CSD) is a benign disease charac-
terized by fever, self-limited regional lymphadenitis, and
skin lesions due to cat scratch or bite. CSD shows a world-
widedistribution and has been mostly reported in children
aged less than 18 yr of age. The etiologic agent of CSD is
Bartonella henselae, a gram-negative rod [1]. Little is
known about the epidemiology of CSD in Korea. Since B.
henselae is fastidious and cannot be grown in cultures,
only 2 CSD cases have been reported using molecular
genetic methods in Korea [2, 3]. Here, we present the third
case of CSD in a Korean pediatric patient; the disease
was confirmed using PCR and DNA sequencing with pri-
mers recently described in the literature.
In September 2008, an 8-yr-old girl presented with
enlargement of both axillary lymph nodes and fever that
had persisted for 2 weeks. The patient had received all
the recommended immunizations. A month before her
admission, a cat had scratched her on the right subclav-
icular area. Investigation of her family history revealed
that her grandmother had been diagnosed with pulmonary
tuberculosis. 
Physical examination of the patient revealed a 2×2 cm
mass on the right axillary lymph node and a 3.5×3 cm
tender and slightly movable mass on the left axillary lymph
node. The skin on the right chest wall showed papular
lesions. The liver, spleen, or other lymph nodes did not
show any apparent enlargement. Yellowish pus was ex-
uded from the left axillary lymph node.
The initial complete blood cell count showed that the
WBC count was 14,710/mL; platelet count, 445,000/mL;
and hemoglobin level, 11.1 g/dL. Mycobacterium tuber-
culosis antigen-specific interferon-gamma release assay
of her serum sample by using QuantiFERON�-TB Gold
IT (Cellestis, Ltd., Carnegie, Australia) and PCR of the
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lymph node aspirate by using AMPLICOR Mycobacteri-
um kitTM (Roche Diagnostic Systems, Inc., Branchburg,
NJ, USA) yielded negative results.
Gram staining of the pus aspirate did not reveal any
organism. Air-dried slides of the pus aspirate were stained
with Warthin-Starry silver stain, and microscopic exam-
ination of these stained slides did not reveal any findings
indicating Bartonella infection. The pus aspirate was cul-
tured on sheep blood agar, MacConkey agar, chocolate
agar, and in thioglycolate broth. The cultured agar plates
and the thioglycolate broth were sealed and incubated in
5% CO2 at 37℃. We examined the plates daily for 4 weeks
for the evidence of microbial growth, but we did not detect
B. henselae growth. We did not perform serological test-
ing of B. henselae antibodies because the kits were una-
vailable.
DNA was extracted from the aspirate using QIAamp
DNA Tissue Mini kit (QUIAGEN, Hilden, Germany). We
performed PCR of the purified template DNA using pri-
mers described by Jensen et al. [4] and Maggi and Bre-
itschwerdt [5]. The primers reported by Maggi and Bre-
itschwerdt [5] targeted 2 consensus regions of the 16S-
23S rRNA intergenic spacer region (ITS) of Bartonella
species, whereas the primers described by Jensen et al. [4]
targeted only 1 region of ITS [4]. Universal 16S rRNA pri-
mers were used as the internal control [6]. PCR amplifi-
cation with the primers described by Maggi and Breitsch-
werdt [5] yielded amplicons with sizes (459 and 684 bp)
corresponding to the 2 consensus regions of the 16S-23S
rRNA ITS of B. henselae. No band was obtained with the
universal 16S rRNA primers, and only nonspecific bands
were observed with the primers described by Jensen et
al. [4]. The PCR products were sequenced using ABI PRISM
BigDye Terminator Cycle Sequencing kit (Applied Bio-
systems, Foster city, CA, USA) and resolved using ABI
PRISM 3730XL analyzer (Applied Biosystems), thereby
revealing a consistent sequence corresponding to the 16S-
23S intergenic spacer region of B. henselae strain Hous-
ton-1 (L35101) with 99.7% identity. The next closest align-
ment (93% identity) of the PCR-amplicon sequence was
to the corresponding sequence of B. koehlerae (AF312490). 
For the first 3 days, the patient received clarithromycin,
which was then switched to azithromycin because of poor
compliance. Her condition improved without any com-
plications, and lymphadenopathy was resolved within 2
weeks.
In immunocompetent children and adolescents, CSD is
usually self-limiting and does not require any antibiotic
treatment. However, azithromycin has shown clinical
efficacy [7], as in our case. The atypical symptoms of CSD
such as bacillary angiomatosis, bacillary peliosis hepatis,
Parinaud’s oculoglandular syndrome, encephalopathy,
endocarditis, and bacteremia may progress to more seri-
ous consequences in 5-20% of CSD patients [8]. Although
some of these symptoms are fatal if left untreated, a treat-
ment protocol for atypical CSD has still not been estab-
lished because of the lack of epidemiologic, clinical, and
diagnostic data [8]. To date, CSD is underdiagnosed in
many countries, probably because of the difficulty in iso-
lation with conventional culture [9]. CSD misdiagnosis is
another potential risk and may lead to unnecessary treat-
ment [8]. Therefore, clinical recognition and accurate dia-
gnosis of CSD is essential.
The clinical diagnosis of CSD is based on the detection
of an enlarged lymph node and possibly a skin lesion at
the contact site. Clinicians should investigate the patient’s
contact history with cats, dogs, rodents, fleas, ticks, or
other blood sucking arthropods. The laboratory diagnos-
tic approaches include culture, histological, serological,
and molecular methods [10]. 
The sample is cultured on blood agar containing 5%
sheep or horse blood and 100 mg/L hemin and incubated
in 5% CO2 at 37℃. B. henselae grows slowly, and a pri-
mary isolate is typically obtained in about 12-14 days.
However, the culturing of Bartonella is still a complicat-
ed process; therefore, only a small number of CSD cases
have been diagnosed using this approach [11]. In our study,
we inoculated the sample on blood agar and chocolate
agar plates and incubated them for 4 weeks, but no Bar-
tonella growth was detected. In addition to culturing, the
aspirate or biopsy specimen may be subjected to histo-
pathologic examination after staining with Warthin-Star-
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ry silver stain, which is neither highly specific nor sen-
sitive for Bartonella species [10]. 
The serological methods for diagnosis indicate serocon-
version or significant increase in the serum anti-B. hen-
selae antibody titer within 15 days. However, the com-
mercialized serological diagnostic kits do not yield con-
sistent results, and the sensitivity of these kits are less-
er than those of molecular methods [12]. 
Since B. henselae cannot be detected using culture or
histology and serological tests lack sensitivity, a confir-
matory diagnosis of CSD is essentially based on PCR [10].
Lymph node aspirate can be easily obtained by fine-nee-
dle aspiration, thereby obviating the need for an excision
biopsy. Molecular methods have successfully identified
the causative organism to the strain-specific level with
enhanced sensitivity and specificity [13]. 
The initial PCR performed using DNA extracted from
0.1 mL of pus specimen was negative for all the above-
described primers. A second PCR performed with DNA
extracted from 1 mL of pus specimen showed bands of
the expected sizes with both Maggi and Breitschwerdt
primers [5]; the absence of these bands in the first PCR
may be attributed to the insufficient amount of template
DNA to overcome the PCR inhibitors in the pus speci-
men [14].
In our study, the internal control (universal 16S rRNA
primer) did not show any amplification. To determine the
reason for this finding, we aligned the 16S rRNA primer
sequence with the nucleotide sequence of B. henselae
and found that only the forward primer had a matching
sequence alignment. Although this primer was designed
to target the conserved 16S rRNA sequence common to
most bacterial species, it failed to identify the 16S rRNA
sequence of B. henselae. Moreover, since the 16S rRNA
genes of Bartonella spp. show more than 97.8% similari-
ty [13], the 16S rRNA gene may not be a suitable target
for Bartonella species identification.
This is the third reported case of cat scratch disease
that was confirmed by PCR for B. henselae in Korea. The
2 previous reports had used the primer sets for the gltA
gene described by Margolis et al. [15] and the primer sets
for the pap31 gene described by Zeaiter et al. [14], which
employed nested PCR. However, in comparison to con-
ventional PCR, nested PCR is more cumbersome, and the
samples are prone contamination; thus, this approach
may not be widely applicable. Therefore, we used conven-
tional PCR to amplify the extracted template DNA with
primers described by Maggi and Breitschwerdt [5], which
targetted the 16S-23S rRNA ITS region. 
In Korea, few clinical or epidemiological studies on B.
henselae have been performed; the dearth of studies can
be attributed to the absence of established diagnostic me-
thods and the lack of clinical recognition for B. henselae
infections. CSD can be overlooked or misdiagnosed in the
absence of proper molecular diagnostic tools. Therefore,
clinicians must consider CSD while diagnosing a patient
presenting with lymphadenopathy and/or fever and thor-
oughly investigate the patient’s contact history with cats
or dogs. As the incidence of CSD increases, appropriate
diagnostic tools that can be widely applied in clinical epi-
demiology may be established.
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